SHREEPUSHK NSE filing

Shree Pushkar Board approves Q2 results, ₹350 crore capex, preferential issue for promoter, and EGM on Dec 10, 2025

The RealCase readHigh impact Positive

Shree Pushkar announced strong Q2/H1 FY26 results, approved ₹350 crore capex for subsidiary expansion, increased authorized capital, and a ₹29.99 crore preferential warrant issue to a promoter. EGM on Dec 10, 2025.

Why it matters

The announcement includes significant strategic decisions: strong financial performance, a large capital expenditure plan for expansion, and a preferential issue to raise funds. These actions will materially impact the company's financial structure, operational capacity, and future growth prospects.

The market read

The company reported strong financial results for Q2 and H1 FY26, demonstrating significant growth in both revenue and profit. The approval of a substantial ₹350 crore capital expenditure for subsidiary expansion and a preferential issue to a promoter indicates confidence in future growth and strategic development.

* The Board of Directors of Shree Pushkar Chemicals & Fertilisers Limited, in its meeting held on November 8, 2025, approved the Unaudited Standalone and Consolidated Financial Results for the Second Quarter and Half Year ended September 30, 2025. * The consolidated revenue from operations for Q2 FY26 increased to ₹25,508.62 lakhs from ₹17,562.28 lakhs in Q2 FY25, with net profit rising to ₹1,820.33 lakhs from ₹1,331.60 lakhs in the same period. * The Board approved a Capital Expenditure of ₹350 crore for the expansion of Madhya Bharat Phosphate Private Limited, a wholly-owned subsidiary, at Meghnagar, Jhabua, Madhya Pradesh. This expansion aims to add 3,00,000 MTPA of Complex Fertilisers, tentatively by March 2028. * The company's Authorised Share Capital will be increased from the existing ₹32.50 crore to ₹33.50 crore, by creating an additional 10 lakh equity shares of ₹10 each. * The Board approved the issuance of up to 7,36,196 Fully Convertible Warrants on a preferential basis to Mr. Gautam Gopikishan Makharia, Promoter and Joint Managing Director, at a price of ₹407.50 each. This aggregates to a total issue size of up to ₹29.99 crore. Each warrant entitles the holder to subscribe to one equity share and is convertible within 18 months. * An Extra-Ordinary General Meeting (EGM) is scheduled for Wednesday, December 10, 2025, at 3:00 p.m. via Video Conferencing/Other Audio Visual Means to approve these proposals. The cut-off date for e-voting is Wednesday, December 3, 2025.

Filing to action

What to do with a filing like this

Shree Pushkar Chemicals & Fertilisers Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.

That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.

See the model portfolios
Primary source

A plain-language summary of a public exchange filing by Shree Pushkar Chemicals & Fertilisers Limited. Read the original for the full detail.

View original filing